These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19835655

  • 21. Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.
    Solé-Padullés C, Lladó A, Bartrés-Faz D, Fortea J, Sánchez-Valle R, Bosch B, Antonell A, Molinuevo JL, Rami L.
    Psychiatry Res; 2011 Jun 30; 192(3):140-6. PubMed ID: 21546220
    [Abstract] [Full Text] [Related]

  • 22. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A, Kojro E, Müller MJ, Scheurich A, Schmidt LG, Fahrenholz F.
    J Geriatr Psychiatry Neurol; 2009 Mar 30; 22(1):3-9. PubMed ID: 19073834
    [Abstract] [Full Text] [Related]

  • 23. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.
    Arch Neurol; 2008 Jan 30; 65(1):94-100. PubMed ID: 18195145
    [Abstract] [Full Text] [Related]

  • 24. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO.
    J Intern Med; 2014 Apr 30; 275(4):418-27. PubMed ID: 24237038
    [Abstract] [Full Text] [Related]

  • 25. Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease.
    Huang J, Auchus AP.
    Ann N Y Acad Sci; 2007 Feb 30; 1097():259-64. PubMed ID: 17413027
    [Abstract] [Full Text] [Related]

  • 26. Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease--a VBM study.
    Leube DT, Weis S, Freymann K, Erb M, Jessen F, Heun R, Grodd W, Kircher TT.
    Int J Geriatr Psychiatry; 2008 Nov 30; 23(11):1114-8. PubMed ID: 18449954
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of diffusion tensor image study in association fiber tracts among normal, amnestic mild cognitive impairment, and Alzheimer's patients.
    Zhang YZ, Chang C, Wei XE, Fu JL, Li WB.
    Neurol India; 2011 Nov 30; 59(2):168-73. PubMed ID: 21483111
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.
    Parnetti L, Lanari A, Silvestrelli G, Saggese E, Reboldi P.
    Mech Ageing Dev; 2006 Feb 30; 127(2):129-32. PubMed ID: 16274728
    [Abstract] [Full Text] [Related]

  • 31. Voxel-based detection of white matter abnormalities in mild Alzheimer disease.
    Xie S, Xiao JX, Gong GL, Zang YF, Wang YH, Wu HK, Jiang XX.
    Neurology; 2006 Jun 27; 66(12):1845-9. PubMed ID: 16801648
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study.
    Zhuang L, Wen W, Zhu W, Trollor J, Kochan N, Crawford J, Reppermund S, Brodaty H, Sachdev P.
    Neuroimage; 2010 Oct 15; 53(1):16-25. PubMed ID: 20595067
    [Abstract] [Full Text] [Related]

  • 34. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
    Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M.
    J Neurol Sci; 2006 Dec 21; 251(1-2):124-8. PubMed ID: 17097109
    [Abstract] [Full Text] [Related]

  • 35. Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia.
    Schönknecht P, Pantel J, Kaiser E, Thomann P, Schröder J.
    Neurosci Lett; 2007 Apr 06; 416(1):39-42. PubMed ID: 17331644
    [Abstract] [Full Text] [Related]

  • 36. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G.
    Brain; 2007 Jul 06; 130(Pt 7):1767-76. PubMed ID: 17522104
    [Abstract] [Full Text] [Related]

  • 37. Age-related alterations in white matter microstructure measured by diffusion tensor imaging.
    Salat DH, Tuch DS, Greve DN, van der Kouwe AJ, Hevelone ND, Zaleta AK, Rosen BR, Fischl B, Corkin S, Rosas HD, Dale AM.
    Neurobiol Aging; 2005 Jul 06; 26(8):1215-27. PubMed ID: 15917106
    [Abstract] [Full Text] [Related]

  • 38. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
    Nordlund A, Rolstad S, Klang O, Lind K, Pedersen M, Blennow K, Edman A, Hansen S, Wallin A.
    J Int Neuropsychol Soc; 2008 Jul 06; 14(4):582-90. PubMed ID: 18577287
    [Abstract] [Full Text] [Related]

  • 39. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N.
    Radiol Med; 2005 Mar 06; 109(3):155-97. PubMed ID: 15775887
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.